Immune Engineering & Cancer ControlEvidence E
Registry Lists an FES PET/CT Study for ER-Positive Breast Cancer
ClinicalTrials.gov posted an observational registration that is enrolling by invitation. No results are posted.
Read the article →Public Beta
The countdown model and news pipeline are under development. Scores are model inputs and may change as evidence is reviewed.
Immortality Countdown
As early as
35YEARS
Until medical progress may begin to outrun biological aging.
Early LEV scenario (P10): 2061 — 35 years from the model's 2026 baseline.
2061
EARLY LEV SCENARIO
Regulatory & Deployment Readiness
Model input · Last reviewed 2026-08-19
15 / 100
Eight Fields of Progress
Current model readiness scores · 8 of 8 fields scored
Rejuvenation & Regeneration
40
Biomarkers & Diagnostics
44
Geroscience Drugs & Trials
33
Gene Therapy & Delivery
36
AI Drug Discovery
52
Organ Replacement & Biofabrication
38
Immune Engineering & Cancer Control
45
Enabling Technology & Automation
50